|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 901 E STREET, NW #500 |
Address2 | |
City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 288670-12
|
||||||||
|
6. House ID# 371000000
|
TYPE OF REPORT | 8. Year | 2011 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Katherine Karl, Senior Counsel |
Date | 07/20/2011 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC and for the Prevention & Public Health Fund, the Affordable Care Act provisions, breast and cervical programs, colorectal cancer programs, tobacco regulation & cessation programs, patient navigator programs, and international health programs, and H. Con. Res. 34, establishing the budget for the U.S. Government for FY 2012.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), White House Office, Centers For Disease Control & Prevention (CDC), State - Dept of (DOS), Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
George |
Kelemen |
|
|
|
Rebekah |
Kuschmider |
|
|
|
David |
Pugach |
|
Fellow for House Committee |
|
Gregg |
Haifley |
|
|
|
Richard |
Woodruff |
|
|
|
Ronald |
Ours |
|
|
|
Mona |
Shah |
|
|
|
Keysha |
Brooks-Coley |
|
Employee of Congresswoman, Senate Committee |
|
Sarah |
Bogdan |
|
Employee of Senator |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues related to implementation of changes to Medicare and Medicaid, pursuant to P.L.111-148, the Patient Protection and Affordable Care Act of 2010. Issues relating to tobacco cessation programs within Medicaid, including S.717 and H.R.6224, H. Con. Res. 34, establishing a budget for the U.S. Government for FY12, S.868 and H.R.1683, the State Flexibility Act (MOE).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
George |
Kelemen |
|
|
|
Mona |
Shah |
|
|
|
Keysha |
Brooks-Coley |
|
Employee of Congresswoman, Senate Committee |
|
Gregg |
Haifley |
|
|
|
Rebekah |
Kuschmider |
|
|
|
Richard |
Woodruff |
|
|
|
Sarah |
Bogdan |
|
Employee of Senator |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Issues related to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L.111-31); (2) cessation and prevention programs authorized as part of P.L.111-148, the Patient Protection & Affordable Care Act of 2010; (3) legislation regarding Congressional review/approval of regulations, including H.R.10, the Regulations from the Executive in Need of Scrutiny
Act of 2011; (4) Framework Convention on Tobacco Control (FCTC); and (5) issues relating to NIH reorganization.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Woodruff |
|
|
|
Gregg |
Haifley |
|
|
|
Ronald |
Ours |
|
|
|
David |
Pugach |
|
Fellow for House Committee |
|
Rebekah |
Kuschmider |
|
|
|
Mona |
Shah |
|
|
|
Keysha |
Brooks-Coley |
|
Employee of Congresswoman, Senate Committee |
|
George |
Kelemen |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Issues relating to the tax treatment of non-profits, deductability of non-profit donations, and governance of non-profit organizations, and the Public Good IRA Rollover Act, S.557, legislation relating to tax extenders.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Woodruff |
|
|
|
Gregg |
Haifley |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H.R.1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S.494, and H.R.912; H.R.1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R.1217, Repeal Prevention & Public Health Fund; S.488, the Access to Cancer Clinical Trials Act of 2009;
H.R.1740 and H.R.5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493, H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.2366, the Cancer Drug Coverage Act of 2009; H.R.4662, The Lymphedema Diagnosis and Treatment Cost Saving Act of 2010; the implementation of P.L.111-148, the Patient Protection and Affordable Care Act of 2010; S.1064, the Sun Act; S.965, the Family Act, and H.R.2077, the MLR Repeal Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Disease Control & Prevention (CDC), Health & Human Services - Dept of (HHS), Labor - Dept of (DOL), White House Office, Food & Drug Administration (FDA), State - Dept of (DOS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Keysha |
Brooks-Coley |
|
Employee of Congresswoman; Senate Committee |
|
David |
Pugach |
|
Fellow for House Committee |
|
George |
Kelemen |
|
|
|
Richard |
Woodruff |
|
|
|
Mona |
Shah |
|
|
|
Rebekah |
Kuschmider |
|
|
|
Gregg |
Haifley |
|
|
|
Ronald |
Ours |
|
|
|
Sarah |
Bogdan |
|
Employee of Senator |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |